Acute Myeloid Leukemia

Acute Myeloid Leukemia in India

Acute myeloid leukemia (AML) and also known as myelogenous leukemia is a type of blood cancer that starts in the myeloid cells

💰
Starting from $34,000
Procedure 30-45 Days
🏨
Stay in India 60-90 Days
Read full treatment guide →

Get a Free Quote

Our coordinators respond within 2 working hours.

🔒 100% confidential. No spam, ever.

🛡️ Free, no obligation ⏱️ 2-hour response 🌍 40+ countries

Your Journey with INDHEAL

1
💬

Free Consultation

Share your medical reports. Our coordinators connect you with the right specialist within 2 working hours.

2
✈️

Travel to India

We arrange your visa letter, airport pickup, and accommodation near the hospital.

3
🏥

Treatment

Your procedure at a JCI or NABH accredited hospital with an internationally trained surgeon.

4
🛌

Recovery

Recuperate comfortably with dedicated nursing care and daily coordinator check-ins.

5
🏡

Follow-up

Return home with full medical records and ongoing remote follow-up from your care team.

Acute Myeloid Leukemia — Key Facts

  • AML is the most common type of leukemia in adults
  • Acute Myeloid Leukemia (AML) is the most lethal form of leukemia
  • Both Acute Myelocytic Leukemia and Acute Myelogenous Leukemia also refer to AML
  • AML is more common in those above the age of 65

Why Choose India for Acute Myeloid Leukemia?

💰

Save 60–80%

World-class treatment at a fraction of US, UK or Australian costs — without compromising on quality.

👨‍⚕️

Expert Surgeons

Internationally trained specialists with thousands of successful procedures and global accreditations.

✈️

No Wait Times

Get treated within days of arrival. Full concierge support for visa, travel and accommodation.

Key Factors to Know

💰

What Affects the Cost?

Understanding what goes into the price helps you plan better.

  • Hospital Type & Location: Premium JCI-accredited private hospitals charge more but offer international-standard care, advanced hematology units, and specialized cancer treatment facilities.
  • Doctor’s Expertise: Treating Acute Myeloid Leukemia (AML) requires highly skilled hematologists experienced in complex chemotherapy, targeted therapy, and transplant protocols. Expertise in risk stratification and deciding the right timing for bone marrow transplant significantly influences outcomes and cost.
  • Type of Therapy: The overall cost depends on the treatment approach—intensive chemotherapy, targeted therapy, or bone marrow transplant (BMT). If a transplant is required, it substantially increases the total treatment cost.
  • Pre & Post-operative Care: Pre-treatment care includes a full medical workup, organ function tests, HLA matching, conditioning therapy, and infection prevention. Post-treatment care involves strict infection control, use of immunosuppressants, and ongoing medication and monitoring as advised.
  • Travel & Accommodation: Additional expenses include flight costs, local accommodation during recovery, medical visa fees, and costs for attendants or caregivers.
🎯

What Affects the Success Rate?

Key factors that influence outcomes for Acute Myeloid Leukemia.

  • Doctor’s Experience: Accurate risk assessment and treatment planning—choosing the most suitable option such as chemotherapy, targeted therapy, or transplant—along with strong complication management and precision care, plays a key role in treatment success.
  • Hospital Accreditation: Opting for JCI or NABH-accredited hospitals ensures high standards of care, safety protocols, and access to advanced hematology facilities.
  • Key Factors Affecting Success Rate: Early detection and lower disease burden improve outcomes. Response to initial chemotherapy, patient age and fitness, eligibility for bone marrow transplant (BMT) and targeted therapies, and strong supportive care during low immunity phases significantly influence survival.
  • Rehabilitation: Includes immune recovery and infection prevention, physical rehabilitation, nutrition support, strict medication adherence, and continuous monitoring.
  • Pre-AML Planning: Involves confirming the diagnosis through bone marrow tests, detailed risk profiling, and selecting the appropriate treatment approach—induction chemotherapy, targeted therapy, or stem cell transplant—based on patient fitness and disease risk.

What Our Patients Say

Aida Ismail

Aida Ismail

Australia · Acute Myeloid Leukemia

My uncle from Ethiopia was diagnosed with Leukemia. He needed urgent treatment overseas as there were no good medical facilities in his home town...After some searching online I reached out to a number of hospitals and companies and the people from INDHEAL responded to me quickly and provided me wit

Frequently Asked Questions

Ready to get started?

Free consultation. No commitment. Response within 2 working hours.

Acute Myeloid Leukemia from $34,000